Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
microbiome
4
×
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
amgen
astrazeneca
bristol-myers squibb
cancer
clinical trials
eli lilly
merck
novartis
avexis
celgene
What
bio
roundup
drug
fda
news
acquisitions
advantages
approved
august
bar
biggest
biotech
brings
build
busy
buy
ceo
companies
company’s
daniel
days
debut
decisions
devices
digital
disease
drugs
dyne’s
epidemic
expect
fatty
frenzied
gamble
gilead
growing
known
led
legacy
liver
market
Language
unset
Current search:
microbiome
×
pfizer
×
" seattle blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More